Pharmacological Jak2 inhibition to overcome androgen receptor aberrations in prostate cancer

Project: Research project

Project Details

Description

Pharmacological Jak2 inhibition to overcome androgen receptor aberrations in prostate cancer
StatusActive
Effective start/end date3/1/222/28/27

Funding

  • MEDICAL COLLEGE OF WISCONSIN
  • NIH NATIONAL CANCER INSTITUTE (NCI)

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.